SCNX
Scienture Holdings, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.37
+0.87%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 821.3K | 431.6K | 136.6K | 1.4M | 10.3M |
| Cost of Revenue | 568.9K | 100.1K | 130.6K | 1.3M | 4.7M |
| Gross Profit | 252.4K | 331.5K | 6.0K | 49.0K | 5.5M |
| Operating Expenses | |||||
| R&D Expense | 2.5M | 2.0M | 2.2M | 100.3K | 993.2K |
| SG&A Expense | 2.0B | 14.5M | 12.1M | 4.4M | 6.6M |
| General & Admin Expense | 2.0B | 14.5M | 12.1M | 3.4M | 6.6M |
| Selling & Marketing Expense | — | — | — | 1.0M | — |
| Other Expenses | (2.0B) | 97.3K | 416.3K | (100.3K) | 875.3K |
| Total Operating Expenses | 14.0M | 16.6M | 14.7M | 4.4M | 8.4M |
| Cost and Expenses | 14.5M | 16.7M | 14.8M | 5.8M | 13.2M |
| Operating Income (EBIT) | (13.7M) | (16.2M) | (14.7M) | (4.4M) | (2.9M) |
| Non-Operating | |||||
| Interest Income | 494.6K | 302.7K | 135.3K | 4.2K | 21.0K |
| Interest Expense | 3.1M | 4.1M | 1.3M | 1.1M | 336.2K |
| Net Interest Income | (2.6M) | (3.8M) | (1.2M) | (1.1M) | (315.2K) |
| Other Non-Op Income/Expense | (26.2M) | (27.3M) | (4.1M) | (4.1M) | 512.5K |
| Non-Operating Income (excl Interest) | 23.3M | 23.2M | 2.7M | 2.9M | (848.7K) |
| EBT (Pre-Tax Income) | (39.9M) | (43.5M) | (18.8M) | (8.5M) | (2.4M) |
| Income Tax Expense | (2.0M) | (2.0M) | (534.4K) | — | — |
| Bottom Line | |||||
| Net Income | (38.0M) | (41.5M) | 9.1M | (17.8M) | (3.5M) |
| Earnings from Cont. Ops | (38.0M) | (41.5M) | (18.2M) | (8.5M) | (2.4M) |
| Earnings from Discont. Ops | — | — | 27.3M | (9.4M) | (1.5M) |
| Bottom Line Net Income | (38.0M) | (41.5M) | 9.1M | (17.8M) | (3.5M) |
| Per Share | |||||
| Basic EPS | ($1.85) | ($2.70) | $2.69 | ($23.35) | ($6.15) |
| Diluted EPS | ($2.04) | ($2.70) | $2.48 | ($7.49) | ($6.15) |
| Revenue Per Share | $0.02 | $0.00 | $0.04 | $1.78 | $18.15 |
| Shares | |||||
| Basic Shares Outstanding | 39.6M | 153.5M | 3.4M | 764058 | 564863 |
| Diluted Shares Outstanding | 39.6M | 153.5M | 3.7M | 2.4M | 564863 |
| Profitability Metrics | |||||
| EBITDA | (36.1M) | (38.9M) | (17.4M) | (6.3M) | (1.9M) |
| D&A | 929.3K | 491.8K | 53.4K | 1.0M | 194.7K |
| EBIT | (37.0M) | (39.4M) | (17.4M) | (7.3M) | (2.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026